Hannah Knowles MPS with David Batt MP, Member for Hinkler (Qld)[/caption]
Anna Theophilos MPS with David Batt MP, Member for Hinkler (Qld)[/caption]
Drawing on 17 years’ experience, Theophilos highlighted the breadth of community pharmacy services she provides, anchored by immunisation.
Using her ‘spin-to-win’ wheel, Anna highlighted the inequity experienced by patients across Australia, with regulations preventing pharmacist immunisers being able to fully support the immunisation needs of the communities they serve.
“I hope they can see it’s common sense that all pharmacists, regardless of where you practice, can vaccinate according to the Australian Immunisation Handbook. All Australians deserve the same access to vaccinations regardless of where they live.
Heading off patient harm from medicines
Medicine adherence, deprescribing and establishing systems to prevent error recurrence are all part of the pharmacist’s calling to protect patient safety.
Pharmacists, as custodians of...
Expert advice for navigating R U OK? conversations
R U OK? Day (14 September) provides the perfect opportunity for pharmacists to check how patients are coping.
Heavy conversations: pharmacy and the obesity epidemic
Pharmacists are in the front line of the obesity epidemic. But counselling patients on diet behaviour can have troubling consequences. Is it time for...
NDSS changes to assist in diabetes management
Changes to the Australian Government’s National Diabetes Services Scheme (NDSS) took effect on 1 December, altering the range and price of certain products available...
R U (really) OK? Tips for checking in
Ahead of R U OK? Day, Australian Pharmacist gets some expert advice on checking in with colleagues about their mental health.
Beyond the pills: navigating depression and antidepressant use in older adults
Depression can significantly impact the lives of older Australians, carers and their families. Pharmacists offer valuable education and support, helping older patients understand the risks and benefits of their treatment and monitoring for adverse effects.
